Cite
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
MLA
Lin, Daniel, et al. “Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, vol. 39, Jan. 2019, pp. e88–95. EBSCOhost, https://doi.org/10.1200/EDBK_236827.
APA
Lin, D., Khan, U., Goetze, T. O., Reizine, N., Goodman, K. A., Shah, M. A., Catenacci, D. V., Al-Batran, S.-E., & Posey, J. A. (2019). Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management? American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 39, e88–e95. https://doi.org/10.1200/EDBK_236827
Chicago
Lin, Daniel, Uqba Khan, Thorsten O Goetze, Natalie Reizine, Karyn A Goodman, Manish A Shah, Daniel V Catenacci, Salah-Eddin Al-Batran, and James A Posey. 2019. “Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 39 (January): e88–95. doi:10.1200/EDBK_236827.